Sponsor Pipeline

Tianjin First Central Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
4
Recruiting
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-12 NCT07759856 NK Cells Plus ICI for SCLC Maintenance Phase 2 Recruiting
2026-07-20 NCT07714577 Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection Not Yet Recruiting
Active Trials by Phase
Phase 2
3
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07697937 YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With… Advanced Malignant Solid Tumor Recruiting
NCT07759856 NK Cells Plus ICI for SCLC Maintenance Small Cell Lung Cancer Recruiting
NCT07707973 Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma Glioma, Malignant Not Yet Recruiting
Not specified
NCT07577934 Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block Postoperative Pain Recruiting
NCT07651722 Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative… Postoperative Pain Recruiting
NCT07173244 A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced… Non-Small Cell Lung Cancer Not Yet Recruiting
NCT07714577 Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection HPV16/18 Positive Not Yet Recruiting
Disease Areas
Get alerts when Tianjin First Central Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free